SOLD: Low cost Vancouver area turnkey craft cultivator – value priced for quick sale at $450k OBO
Micro craft cultivator with direct delivery to stores in BC and 2 other Provinces. Closest LP to Metropolitan Vancouver at a truly bargain price!
Listing ID:
10303179152
Licence(s) Held:
Micro Cultivation and CRA licence
Listing Details:
A leased, fully operational, purpose-designed ~3,275 ft.² indoor micro cultivation facility located 23 mins from Vancouver in BC
Facility is comprised of 5 grow rooms, a processing area, 1 secure storage room, 1 drying room, record storage room, office and a shipping receiving area
Each room contains a two-stage heat pump, 2 Anden dehumidifiers, Sanuvox UV light, CO2 burner, 16 Fluence spydr lights, PIP racking for multiple levels
Currently undertaking cultivation, drying, sales, bulk packaging, storage, and contracted pre-roll manufacturing
Full production capability of ~500 kg/year of dried flower
Projecting $1.2 million gross revenue for 2023 with super-lean operating costs
The facility is ripe for future expansion
Seeking outright divestiture of the business, licence and lease for $450k o.b.o
ACT FAST TO SECURE THIS VALUE-PRICED LOWER-MAINLAND CULTIVATION GEM IN THE HEART OF CANNABIS COUNTRY
OUR NEWEST CANNABIS BUSINESS LISTINGS
Explore the newest cannabis business opportunities hitting the market. If you're looking to invest, acquire, or expand your enterprise, these listings are the ideal starting point to grow your footprint in the cannabis industry.
50240015963
Licensed pharmaceutical distribution platform and market entry hub in Poland for €675K OBO
A licensed, operational, GDP-aligned pharmaceutical wholesaler in Poland providing immediate market access for medical cannabis through established distribution channels and controlled-substance authorizations. Company seeks a 51% to 100% equity sale.
36324927098
Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner
Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential